Abstract
ALS causes the degeneration of motor neurons in cortex, brainstem and spinal cord with consequent paralysis and death.1 Most cases of ALS are sporadic and have an unknown etiology.2 However, about 10–15% of all ALS cases are inherited. An adultonset, autosomal dominantly inherited trait is the predominant form3, although there is a rare, recessively inherited childhood-onset form of ALS in which survival can be quite long4. In 1991, a fraction of families with the familial form of ALS (FALS) showed linkage to a disease locus on human chromosome 21q.5 Shortly thereafter, in 1993, the target of mutation on chromosome 21q was shown to be the gene (SOD1) encoding Cu,Zn Superoxide dismutase (Cu,Zn SOD). At least 22 different missense mutations causing the substitution of one amino acid for another have now been found in FALS kindreds. Cu,Zn SOD is a metalloenzyme that catalyzes the dismutation of Superoxide (O2×-) to hydrogen peroxide (H2O2). The copper ion provides the redox center for the dismutation of Superoxide, while the zinc ion plays a structural role. Three different genes encoding Superoxide dismutases are present in the human genome. All three enzymes contain a transition metal in their active site, but differ in their subcellular localization. Only Cu,Zn SOD is mutated in FALS. Cu,Zn SOD is primarily cytosolic and is expressed in every cell within the body.6,7 Why only motor neurons are affected by the mutations found in FALS is unknown. The mutations of Cu,Zn SOD found in affected families are primarily amino acid substitutions in structural regions of the polypeptide.8 No deletions of the human SOD1 gene have been described which suggests that expression of the mutant polypeptide is required for pathogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mulder, D.W. (1982) Clinical limits of amyotrophic lateral sclerosis. In: Rowland, L.P., (Ed.) Human Motor Neuron Diseases, pp. 15-22. New York: Raven Press.
Tandan, R. and Bradley, W.G. (1985) Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology and ethical issues in management. Ann. Neurol. 18, 271–280.
Mulder, D.W., Kurland, L.T., Offord, K.P., and Beard, CM. (1986) Familial adult motor neuron disease: Amyotrophic lateral sclerosis. Neurol. 36, 511–517.
Ben Hamida, M., Hentati, F., and Ben Hamida, C. (1990) Hereditary motor system diseases (chronic juvenile amyorophic lateral sclerosis): conditions combining a bilateral pyramidal syndrome with limb and bulbar atrophy. Brain 113, 347–363.
Siddique, T et al. (1994) Linkage of a gene causing familial amyotropic lateral sclerosis to chromosome 21 and evidence of locus heterogeneity. New Englnd. J. Med. 324, 1381–1384.
Crapo, J.D., Oury, T., Rabouille, C., Slot, J.W., and Chang, L-Y. (1992) Copper, zinc Superoxide dismutase is primarily a cytosolic protein in human cells. Proc. Natl. Acad. Sci. USA 89, 10405–10409.
Beckman, J.S., Carson, M., Smith, C.D. and Koppenol, W.H. (1993) ALS, SOD and peroxynitrite. Nature 364, 584.
Deng, H.X. et al. (1993) Amyotrophic lateral sclerosis and structural defects in Cu,Zn Superoxide dismutase. Science 261, 1047–1051.
Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., Deng, H.-X., et al. (1994) Motor neuron degeneration in mice expressing a human Cu, Zn Superoxide dismutase mutation. Science 264, 1772–1775.
Ripps, M.E., Huntley, G.W., Hof, P.R., Morrison, J.H., and Gordon, J.W. (1995) Transgenic mice expressing an altered murine Superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 92, 689–693.
Price, D. et al., see chapter from this symposium.
Avraham, K.B., Sugarman, H., Rotshenker, S. and Groner, Y. (1991) Down’s syndrome: morphological remodelling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase mice. J. Neurocytol. 20, 208–215.
Avraham, K.B., Schickler, M., Sapoznikov, D., Yarom, R. and Groner, Y. (1988) Down’s syndrome: Abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu,Zn-superoxide dismutase. Cell 54, 823–829.
Dal Canto, M.C. and Gurney, M.E. (1994) The development of CNS pathology in a murine transgenic model of human ALS. Am. J. Pathol. 145, 1271–1280.
Przedborski, S., Kostic, V., Jackson-Lewis, V., Naini, A.B., Simonetti, S., Fahn, S., Carlson, E., Epstein, C.J., and Cadet, J.L. (1992) Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to Nmethyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12, 1658–1667.
Yang, G., Chan, P.H., Chen, J., Carlson, E., Chen, S.F., Weinstein, P., Epstein, C.J. and Kamii, H. (1994) Human copper-zinc Superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25, 165–70.
Epstein, C.J., Avraham, K.B., Lovett, M., Smith, S., Elroy-Stein, O., Rotman, G., Bry, C and Groner, Y. (1987) Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. USA 84, 8044–8048.
Borchelt, D.R. et al. (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA 91, 8292–8296.
Benz, R. (1990) Biphysical properties of porin pores from mitochondrial outer membrane of eukaryotic cells. Experientia 46, 131–137.
Weisiger, R.A. and Fridovich, I. (1973) Mitochondrial Superoxide dismutase. Site of synthesis and intramitochondrial localization. J. Biol. Chem. 248, 4793–4796.
Liou, W., Chang, L.Y. Geuze, HJ. Strous, G.J. Crapo, J.D. and Slot, J.W. (1993) Distribution of CuZn Superoxide dismutase in rat liver. Free Radical Biol. Med. 14, 201–207.
Yim, M.B., Chock, P.B. and Stadtman, E.R. (1993) Enzyme function of copper, zinc Superoxide dismutase as a free radical generator. J. Biol. Chem. 268, 4099–4105.
Beekman, J.S., Carson, M., Smith, C.D. and Koppenol, W.H. (1993) ALS, SOD and peroxynitrite. Nature 364, 584.
Ribarov, S.R. and Bochev, P.G. (1984) The interaction of copper chloride with the erythrocyte membrane as a source of activated oxygen species. Gen. Physiol. Biophys. 3, 431–435.
Ogasawara, M. et al. (1993) Mild ALS in Japan associated with novel SOD mutation. Nature Genetics 5, 323–324.
Caffi, M.T., Battistoni, A., Polizio, F., Desideri, A., and Rotilio, G. (1994) Impaired copper binding by the H46R mutant of human Cu,Zn Superoxide dismutase, invovled in amyotrophic lateral sclerosis. FEBS Letters 356, 314–316.
Selkoe, D. J. (1994) Alzheimer’s disease: a central role for amyloid J. Neuropathol. Exp. Neurol. 53, 427–428.
Tu, P.-H., Raju, P., Robinson, K.A., Gurney, M.E., Trojanowski, J.Q., and Lee, V. M.-Y. (1995) Transgenic mice carrying a human mutant Superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. in press..
Collard, J.-F., Cote, F. and Julien, J.-P. (1995) Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature 375, 61–64.
Shaw, P.J. (1994) Excitotoxicity and motor neurone disease. J. Neurol. Sci. 124(Suppl.), 6–13.
Choi, D.W. (1988) Glutamate neurotoxicity and disease of the nervous system. Neuron 1, 623–634.
Ince, P.G. et al. (1992) Parvalbumin and calbindin D-28K in the human motor system and in motor neuron disease. Neuropathol. Appl. Neurobiol..
Bensimon G. Lacomblez L. Meininger V. (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis. New Englnd. J. Med. 330, 585–591.
Plaitakis, A. Mandeli, J., Fesdjian, C. and Sivak, M.A. (1991) Dysregulation of glutamate metabolism in ALS: correlation with gender and disease type. Neurol. 41, 392–393.
Rothstein, J.D. et al. (1990) Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 28, 18–25.
Rothstein, J.D., Martin, L.J., and Kuncl, R.W. (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. New Englnd. J. Med. 326, 1464–1468.
Fix, A.S. et al. (1993) Neuronal vacuolization and necrosis induced by the noncompetitive N-metyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): A light and electron microscopic evaluation of rat retrosplenial cortex. Exp. Neurol. 123, 204–215.
Bowling, A.C., Schulz, J.B., Brown, R.H. Jr, and Beal, F.M. (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61, 2322–2325.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gurney, M.E., Chiu, A.Y., Canto, M.C.D., Trojanowski, J.Q., Lee, V.MY. (1996). Mutations of Human Cu, Zn Superoxide Dismutase Expressed in Transgenic Mice Cause Motor Neuron Disease. In: Fiskum, G. (eds) Neurodegenerative Diseases. GWUMC Department of Biochemistry and Molecular Biology Annual Spring Symposia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0209-2_17
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0209-2_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0211-5
Online ISBN: 978-1-4899-0209-2
eBook Packages: Springer Book Archive